Moderate exercise as an adjuvant therapy for treatment-resistant major depressive disorder: 6-month follow-up

Aerobic Exercise: Health Benefits, Types and Common Misconceptions

Volumn , Issue , 2013, Pages 85-111

  Mota Pereira, Jorge ^a,b,c   Silverio, Jorge ^a   Fonte, Daniela ^d   Carvalho, Serafim ^c   Ramos, Joaquim ^c   Ribeiro, Jose Carlos ^e  

^a UNIVERSITY OF MINHO   (Portugal)

^b Clínica Médico Psiquiátrica da Ordem   (Portugal)

^c Institute of Biomedical Sciences Abel Salazar   (Portugal)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

Depression; Follow up; Functioning; Physical activity; Quality of life; Relapse; Remission

Indexed keywords

EID: 84893869396     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (159)

1. World Health Organization. Global Recommendations on Physical Activity for Health. 2010.
2. Freeman MP. Complementary and Alternative Medicine (CAM): considerations for the treatment of major depressive disorder. J. Clin. Psychiatry. 2009;70 Suppl 5:4-6.:4-6.
3. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Medicine and science in sports and exercise. 2007;39(8):1423-34.
4. Davidson JR. Major depressive disorder treatment guidelines in America and Europe. J. Clin. Psychiatry. 2010;71 Suppl E1:e04.:e04.
5. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 3rd. edition. 2010.
6. UK Department of Health. Exercise Referral Systems: A National Quality Assurance Framework. 2001.
7. Mota-Pereira J, Silverio J, Carvalho S, Ramos J, Ribeiro JC. Physical Exercise and Major Depressive Disorder -Where do We Stand? Current Psychopharmacology. 2012;1(2):167-77.
8. Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, Moore K, et al. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000;62(5):633-8.
9. Doyne EJ, Ossip-Klein DJ, Bowman ED, Osborn KM, McDougall-Wilson IB, Neimeyer RA. Running versus weight lifting in the treatment of depression. J. Consult Clin. Psychol. 1987;55(5):748-54.
10. Fremont J, Craighead LW. Aerobic exercise and cognitive therapy in the treatment of dysphoric moods. Cognit. Ther. Res. 1987;11:241-51.
11. Hoffman BM, Babyak MA, Craighead WE, Sherwood A, Doraiswamy PM, Coons MJ, et al. Exercise and pharmacotherapy in patients with major depression: one-year followup of the SMILE study. Psychosom Med. 2011;73(2):127-33.
12. Kerse N, Hayman KJ, Moyes SA, Peri K, Robinson E, Dowell A, et al. Home-based activity program for older people with depressive symptoms: DeLLITE--a randomized controlled trial. Ann. Fam. Med. 2010;8(3):214-23.
13. Krogh J, Nordentoft M, Sterne JA, Lawlor DA. The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. J. Clin. Psychiatry. 2011;72(4):529-38.
14. Oeland AM, Laessoe U, Olesen AV, Munk-Jorgensen P. Impact of exercise on patients with depression and anxiety. Nord J. Psychiatry. 2010;64(3):210-7.
15. Sims J, Hill K, Davidson S, Gunn J, Huang N. Exploring the feasibility of a community-based strength training program for older people with depressive symptoms and its impact on depressive symptoms. BMC Geriatrics. 2006;6:18.
16. Singh NA, Clements KM, Singh MA. The efficacy of exercise as a long-term antidepressant in elderly subjects: a randomized, controlled trial. J. Gerontol. A. Biol. Sci. Med. Sci. 2001;56(8):M497-M504.
17. Mota-Pereira J, Silverio J, Carvalho S, Ribeiro JC, Fonte D, Ramos J. Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder. J. Psychiatr. Res. 2011;45(8):1005-11.
18. Mota-Pereira J, Carvalho S, Silverio J, Fonte D, Pizarro A, Teixeira J, et al. Moderate physical exercise and quality of life in patients with treatment-resistant major depressive disorder. J. Psychiatr. Res. 2011;45(12):1657-9.
19. Deslandes AC, Moraes H, Alves H, Pompeu FA, Silveira H, Mouta R, et al. Effect of aerobic training on EEG alpha asymmetry and depressive symptoms in the elderly: a 1-year follow-up study. Braz. J. Med. Biol. Res. 2010;43(6):585-92.
20. Cichon S, Craddock N, Daly M, Faraone SV, Gejman PV, Kelsoe J, et al. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. American Journal of Psychiatry. 2009;166(5):540-56.
21. Barlow JH, Barefoot J. Group education for people with arthritis. Patient Educ. Couns. 1996;27(3):257-67.
22. Baum JG, Clark HB, Sandler J. Preventing relapse in obesity through posttreatment maintenance systems: comparing the relative efficacy of two levels of therapist support. J. Behav. Med. 1991;14(3):287-302.
23. Rybarczyk B, DeMarco G, DeLaCruz M, Lapidos S, Fortner B. A classroom mind/body wellness intervention for older adults with chronic illness: comparing immediate and 1-year benefits. Behav. Med. 2001;27(1):15-27.
24. Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13(1):39-46.
25. Fontaine KR, Conn L, Clauw DJ. Effects of lifestyle physical activity in adults with fibromyalgia: results at follow-up. J. Clin. Rheumatol. 2011;17(2):64-8.
26. Wigers SH, Stiles TC, Vogel PA. Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scand. J. Rheumatol. 1996;25(2):77-86.
27. Ang D, Kesavalu R, Lydon JR, Lane KA, Bigatti S. Exercise-based motivational interviewing for female patients with fibromyalgia: a case series. Clin. Rheumatol. 2007;26(11):1843-9.
28. Asbury EA, Chandrruangphen P, Collins P. The importance of continued exercise participation in quality of life and psychological well-being in previously inactive postmenopausal women: a pilot study. Menopause. 2006;13(4):561-7.
29. Wang CY, Yeh CJ, Wang CW, Wang CF, Lin YL. The health benefits following regular ongoing exercise lifestyle in independent community-dwelling older Taiwanese adults. Australas J. Ageing. 2011;30(1):22-6.
30. Brown DR, Morgan WP, Raglin JS. Effects of exercise and rest on the state anxiety and blood pressure of physically challenged college students. J. Sports Med. Phys. Fitness. 1993;33(3):300-5.
31. Glazer A, O'Connor P. Mood improvements following exercise and quiet rest in bulimic women. Scand. J. Med. Sci. Sports. 1992;3:73-9.
32. Fox K. The physical self and processes in self-esteem development. In: K.R. Fox, (editor.) The physical self: from motivation to well-being. Champaign, Illinois: Human Kinetics; 1997.
33. Bandura A. Self-regulation of motivation through anticipatory and self-reactive mechanisms. Nebr. Symp. Motiv. 1990;38:69-164.
34. Kirkcaldy BD, Shephard RJ, Siefen RG. The relationship between physical activity and self-image and problem behaviour among adolescents. Social psychiatry and psychiatric epidemiology. 2002;37(11):544-50.
35. Maciejewski PK, Prigerson HG, Mazure CM. Self-efficacy as a mediator between stressful life events and depressive symptoms. Differences based on history of prior depression. Br. J. Psychiatry. 2000;176:373-8.
36. Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, Barbour KA, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom. Med. 2007;69(7):587-96.
37. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am. J. Prev. Med. 2005;28(1):1-8.
38. Hacker E. Exercise and quality of life: strengthening the connections. Clin. J. Oncol. Nurs. 2009;13(1):31-9.
39. Malt UF. Exercise in the treatment of major depressive disorder: still a long way to go. Psychosom. Med. 2008;70(2):263-5.
40. Ransford CP. A role for amines in the antidepressant effect of exercise: a review. Medicine and science in sports and exercise. 1982;14(1):1-10.
41. Dunn AL, Dishman RK. Exercise and the neurobiology of depression. Exerc. Sport Sci. Rev. 1991;19:41-98.
42. Sachar EJ, Nathan RS, Asnis G, Halbreich U, Tabrizi MA, Halpern F. Neuroendocrine studies of major depressive disorder. Acta Psychiatr Scand. Suppl. 1980;280:201-10.
43. Kendler KS, Mohs RC, Davis KL. The effects of diet and physical activity on plasma homovanillic acid in normal human subjects. Psychiatry Res. 1983;8(3):215-23.
44. Soares J, Naffah-Mazzacoratti MG, Cavalheiro EA. Increased serotonin levels in physically trained men. Braz. J. Med. Biol. Res. 1994;27(7):1635-8.
45. Arida RM, Naffah-Mazzacoratti MG, Soares J, Cavalheiro EA. Monoamine responses to acute and chronic aerobic exercise in normotensive and hypertensive subjects. Sao Paulo Med. J. 1998;116(1):1618-24.
46. Devalon ML, Miller TD, Squires RW, Rogers PJ, Bove AA, Tyce GM. Dopa in plasma increases during acute exercise and after exercise training. J. Lab. Clin. Med. 1989;114(3):321-7.
47. Fatouros I, Chatzinikolaou A, Paltoglou G, Petridou A, Avloniti A, Jamurtas A, et al. Acute resistance exercise results in catecholaminergic rather than hypothalamicpituitary-adrenal axis stimulation during exercise in young men. Stress. 2010;13(6):461-8.
48. Oleshansky MA, Zoltick JM, Herman RH, Mougey EH, Meyerhoff JL. The influence of fitness on neuroendocrine responses to exhaustive treadmill exercise. Eur. J. Appl. Physiol. Occup. Physiol. 1990;59(6):405-10.
49. Poehlman ET, Jr DE. Endurance training increases metabolic rate and norepinephrine appearance rate in older individuals. Am. J. Physiol. 1991;261(2 Pt 1):E233-E9.
50. Young DB, Srivastava TN, Fitzovich DE, Kivlighn SD, Hamaguchi M. Potassium and catecholamine concentrations in the immediate post exercise period. Am. J. Med. Sci. 1992;304(3):150-3.
51. Strachan AT, Maughan RJ. Platelet serotonin transporter density and related parameters in endurance-trained and sedentary male subjects. Acta Physiol. Scand. 1998;163(2):165-71.
52. Carroll JF, Convertino VA, Wood CE, Graves JE, Lowenthal DT, Pollock ML. Effect of training on blood volume and plasma hormone concentrations in the elderly. Medicine and science in sports and exercise. 1995;27(1):79-84.
53. Hagberg JM, Hickson RC, McLane JA, Ehsani AA, Winder WW. Disappearance of norepinephrine from the circulation following strenuous exercise. J. Appl. Physiol. 1979;47(6):1311-4.
54. Dwyer D, Flynn J. Short term aerobic exercise training in young males does not alter sensitivity to a central serotonin agonist. Exp. Physiol. 2002;87(1):83-9.
55. Rogers PJ, Tyce GM, Weinshilboum RM, O'Connor DT, Bailey KR, Bove AA. Catecholamine metabolic pathways and exercise training. Plasma and urine catecholamines, metabolic enzymes, and chromogranin-A. Circulation. 1991;84(6):2346-56.
56. Meeusen R. Exercise and the brain: insight in new therapeutic modalities. Ann. Transplant. 2005;10(4):49-51.
57. Thoren P, Floras JS, Hoffmann P, Seals DR. Endorphins and exercise: physiological mechanisms and clinical implications. Medicine and science in sports and exercise. 1990;22(4):417-28.
58. Boecker H, Sprenger T, Spilker ME, Henriksen G, Koppenhoefer M, Wagner KJ, et al. The runner's high: opioidergic mechanisms in the human brain. Cerebral cortex (New York, NY:1991). 2008;18(11):2523-31.
59. Daniel M, Martin AD, Carter J. Opiate receptor blockade by naltrexone and mood state after acute physical activity. Br. J. Sports Med. 1992;26(2):111-5.
60. Lobstein DD, Rasmussen CL, Dunphy GE, Dunphy MJ. Beta-endorphin and components of depression as powerful discriminators between joggers and sedentary middle-aged men. J. Psychosom. Res. 1989;33(3):293-305.
61. Opasich C, Cobelli F, Farilla C, Riccardi G, Bosco L, La Rovere MT, et al. Silent ischaemia in post-myocardial infarction patients submitted to physical training. Eur. Heart J. 1988;9 Suppl M:22-7.:22-7.
62. Sheps DS, Adams KF, Hinderliter A, Price C, Bissette J, Orlando G, et al. Endorphins are related to pain perception in coronary artery disease. Am. J. Cardiol. 1987;59(6):523-7.
63. Deslandes A, Moraes H, Ferreira C, Veiga H, Silveira H, Mouta R, et al. Exercise and mental health: many reasons to move. Neuropsychobiology. 2009;59(4):191-8.
64. Hatfield BD, Goldfarb AH, Sforzo GA, Flynn MG. Serum beta-endorphin and affective responses to graded exercise in young and elderly men. J. Gerontol. 1987;42(4):429-31.
65. Williams JM, Getty D. Effect of levels of exercise on psychological mood states, physical fitness, and plasma beta-endorphin. Percept Mot. Skills. 1986;63(3):1099-105.
66. Thase ME, Pritchett YL, Ossanna MJ, Swindle RW, Xu J, Detke MJ. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. J. Clin. Psychopharmacol. 2007;27(6):672-6.
67. Maletic V, Raison CL. Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci. 2009;14:5291-338.
68. Duman RS. Neurotrophic factors and regulation of mood: role of exercise, diet and metabolism. Neurobiol Aging. 2005;26 Suppl 1:88-93.
69. Mata J, Thompson RJ, Gotlib IH. BDNF genotype moderates the relation between physical activity and depressive symptoms. Health Psychol. 2010;29(2):130-3.
70. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry. 2006;59(12):1116-27.
71. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002;109(2):143-8.
72. Laske C, Banschbach S, Stransky E, Bosch S, Straten G, Machann J, et al. Exerciseinduced normalization of decreased BDNF serum concentration in elderly women with remitted major depression. Int. J. Neuropsychopharmacol. 2010;13(5):595-602.
73. Neeper SA, Gomez-Pinilla F, Choi J, Cotman CW. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. 1996;726(1-2):49-56.
74. Oliff HS, Berchtold NC, Isackson P, Cotman CW. Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res. Mol. Brain Res. 1998;61(1-2):147-53.
75. Gustafsson G, Lira CM, Johansson J, Wisen A, Wohlfart B, Ekman R, et al. The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder. Psychiatry Res. 2009;169(3):244-8.
76. Adlard PA, Cotman CW. Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience. 2004;124(4):985-92.
77. Cassilhas RC, Viana VA, Grassmann V, Santos RT, Santos RF, Tufik S, et al. The impact of resistance exercise on the cognitive function of the elderly. Medicine and science in sports and exercise. 2007;39(8):1401-7.
78. Landi F, Capoluongo E, Russo A, Onder G, Cesari M, Lulli P, et al. Free insulin-like growth factor-I and cognitive function in older persons living in community. Growth hormone and IGF research: official journal of the Growth Hormone Research Society and the International IGF Research Society. 2007;17(1):58-66.
79. Roy S, Khanna S, Sen CK. Redox regulation of the VEGF signaling path and tissue vascularization: Hydrogen peroxide, the common link between physical exercise and cutaneous wound healing. Free radical biology and medicine. 2008;44(2):180-92.
80. Fabel K, Tam B, Kaufer D, Baiker A, Simmons N, Kuo CJ, et al. VEGF is necessary for exercise-induced adult hippocampal neurogenesis. Eur J Neurosci. 2003;18(10):2803-12.
81. Pereira AC, Huddleston DE, Brickman AM, Sosunov AA, Hen R, McKhann GM, et al. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(13):5638-43.
82. Ernst C, Olson AK, Pinel JP, Lam RW, Christie BR. Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis? J. Psychiatry Neurosci. 2006;31(2):84-92.
83. Hoffman BM, Blumenthal JA, Babyak MA, Smith PJ, Rogers SD, Doraiswamy PM, et al. Exercise fails to improve neurocognition in depressed middle-aged and older adults. Medicine and science in sports and exercise. 2008;40(7):1344-52.
84. Weydahl A. Evening melatonin in January after changes in hours of habitual exercise during fall among youths living in the subarctic. Arctic Med. Res. 1994;53(3):146-51.
85. Baehr EK, Eastman CI, Revelle W, Olson SH, Wolfe LF, Zee PC. Circadian phaseshifting effects of nocturnal exercise in older compared with young adults. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003;284(6):R1542-R50.
86. Barger LK, Wright KP, Jr., Hughes RJ, Czeisler CA. Daily exercise facilitates phase delays of circadian melatonin rhythm in very dim light. Am. J. Physiol. Regul Integr. Comp. Physiol. 2004;286(6):R1077-R84.
87. Buxton OM, Frank SA, L'Hermite-Baleriaux M, Leproult R, Turek FW, Van Cauter E. Roles of intensity and duration of nocturnal exercise in causing phase delays of human circadian rhythms. Am. J. Physiol. 1997;273(3 Pt 1):E536-E42.
88. Buxton OM, L'Hermite-Baleriaux M, Hirschfeld U, Cauter E. Acute and delayed effects of exercise on human melatonin secretion. J. Biol. Rhythms. 1997;12(6):568-74.
89. Copinschi G, Spiegel K, Leproult R, Van Cauter E. Pathophysiology of human circadian rhythms. Novartis Found Symp. 2000;227:143-57; discussion 157-62.:143-57.
90. Lack LC, Wright HR. Chronobiology of sleep in humans. Cell Mol. Life Sci. 2007;64(10):1205-15.
91. Marrin K, Drust B, Gregson W, Morris CJ, Chester N, Atkinson G. Diurnal variation in the salivary melatonin responses to exercise: relation to exercise-mediated tachycardia. Eur. J. Appl. Physiol. 2011;111(11):2707-14.
92. Mistlberger RE, Skene DJ. Nonphotic entrainment in humans? J. Biol. Rhythms. 2005;20(4):339-52.
93. Miyazaki T, Hashimoto S, Masubuchi S, Honma S, Honma KI. Phase-advance shifts of human circadian pacemaker are accelerated by daytime physical exercise. Am. J. Physiol. Regul Integr. Comp. Physiol. 2001;281(1):R197-R205.
94. Thorpy M. Understanding and diagnosing shift work disorder. Postgrad Med. 2011;123(5):96-105.
95. Van Reeth O, Sturis J, Byrne MM, Blackman JD, L'Hermite-Baleriaux M, Leproult R, et al. Nocturnal exercise phase delays circadian rhythms of melatonin and thyrotropin secretion in normal men. Am. J. Physiol. 1994;266(6 Pt 1):E964-E74.
96. Buxton OM, Lee CW, L'Hermite-Baleriaux M, Turek FW, Van Cauter E. Exercise elicits phase shifts and acute alterations of melatonin that vary with circadian phase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003;284(3):R714-R24.
97. Cain SW, Rimmer DW, Duffy JF, Czeisler CA. Exercise distributed across day and night does not alter circadian period in humans. J. Biol. Rhythms. 2007;22(6):534-41.
98. Horowitz TS, Tanigawa T. Circadian-based new technologies for night workers. Ind. Health. 2002;40(3):223-36.
99. Yamanaka Y, Hashimoto S, Tanahashi Y, Nishide SY, Honma S, Honma K. Physical exercise accelerates reentrainment of human sleep-wake cycle but not of plasma melatonin rhythm to 8-h phase-advanced sleep schedule. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010;298(3):R681-R91.
100. Taylor A. Physical activity, anxiety, and stress. In: Biddle SJH, Fox KR, Boutcher SH, (editors.) Physical activity and psychological well-being. London: Routledge; 2012.
101. Singh A, Petrides JS, Gold PW, Chrousos GP, Deuster PA. Differential hypothalamicpituitary-adrenal axis reactivity to psychological and physical stress. J. Clin. Endocrinol. Metab. 1999;84(6):1944-8.
102. Silverman HG, Mazzeo RS. Hormonal responses to maximal and submaximal exercise in trained and untrained men of various ages. J. Gerontol. A. Biol. Sci. Med. Sci. 1996;51(1):B30-B7.
103. Stewart AL, Hays RD, Wells KB, Rogers WH, Spritzer KL, Greenfield S. Long-term functioning and well-being outcomes associated with physical activity and exercise in patients with chronic conditions in the Medical Outcomes Study. J. Clin. Epidemiol. 1994;47(7):719-30.
104. Singh NA, Clements KM, Fiatarone MA. A randomized controlled trial of progressive resistance training in depressed elders. J. Gerontol. A. Biol. Sci. Med. Sci. 1997;52(1):M27-M35.
105. Sanudo B, Galiano D, Carrasco L, de Hoyo M, McVeigh JG. Effects of a prolonged exercise program on key health outcomes in women with fibromyalgia: a randomized controlled trial. J. Rehabil Med. 2011;43(6):521-6.
106. Motl RW, McAuley E. Pathways between physical activity and quality of life in adults with multiple sclerosis. Health Psychol. 2009;28(6):682-9.
107. Motl RW, McAuley E, Snook EM, Gliottoni RC. Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support. Psychol Health Med. 2009;14(1):111-24.
108. Carta MG, Hardoy MC, Pilu A, Sorba M, Floris AL, Mannu FA, et al. Improving physical quality of life with group physical activity in the adjunctive treatment of major depressive disorder. Clin Pract Epidemiol Ment Health. 2008;4:1.
109. Weinstein AA, Deuster PA, Kop WJ. Heart rate variability as a predictor of negative mood symptoms induced by exercise withdrawal. Medicine and science in sports and exercise. 2007;39(4):735-41.
110. Evcik D, Yigit I, Pusak H, Kavuncu V. Effectiveness of aquatic therapy in the treatment of fibromyalgia syndrome: a randomized controlled open study. Rheumatol Int. 2008;28(9):885-90.
111. Asbury EA, Slattery C, Grant A, Evans L, Barbir M, Collins P. Cardiac rehabilitation for the treatment of women with chest pain and normal coronary arteries. Menopause. 2008;15(3):454-60.
112. Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, et al. Fatigue, mood and quality of life improve in MS patients after progressive resistance training. Mult Scler. 2010;16(4):480-90.
113. Lemstra M, Stewart B, Olszynski WP. Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial. Headache. 2002;42(9):845-54.
114. Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J. Clin. Oncol. 2009;20(27):4605-12.
115. Chueire VB, Silva ET, Perotta E, Romaldini JH, Ward LS. High serum TSH levels are associated with depression in the elderly. Arch. Gerontol. Geriatr. 2003;36(3):281-8.
116. Demet MM, Ozmen B, Deveci A, Boyvada S, Adiguzel H, Aydemir O. Depression and anxiety in hyperthyroidism. Arch. Med. Res. 2002;33(6):552-6.
117. Rack SK, Makela EH. Hypothyroidism and depression: a therapeutic challenge. Ann. Pharmacother. 2000;34(10):1142-5.
118. Ogasawara T, Itoh Y, Tamura M, Ukai Y, Yoshikuni Y, Kimura K. NS-3, a TRHanalog, reverses memory disruption by stimulating cholinergic and noradrenergic systems. Pharmacol. Biochem. Behav. 1996;53(2):391-9.
119. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A metaanalysis of cytokines in major depression. Biol. Psychiatry. 2010;67(5):446-57.
120. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24-31.
121. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, et al. Cytokineassociated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry. 2001;58(5):445-52.
122. Wright CE, Strike PC, Brydon L, Steptoe A. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav. Immun. 2005;19(4):345-50.
123. Capuron L, Miller AH. Cytokines and psychopathology: lessons from interferon-alpha. Biol. Psychiatry. 2004;56(11):819-24.
124. Asnis GM, De La GR. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J. Clin. Gastroenterol. 2006;40(4):322-35.
125. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry. 2009;65(9):732-41.
126. Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 2007;21(1):9-19.
127. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9(1):46-56.
128. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 2012;36(2):764-85.
129. McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 2009;33(3):355-66.
130. Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatry. 2010;68(8):748-54.
131. Black PH. The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav. Immun. 2003;17(5):350-64.
132. Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiatry. 1999;156(6):837-41.
133. Miller AH. Inflammation versus glucocorticoids as purveyors of pathology during stress: have we reached the tipping point? Biol. Psychiatry. 2008;64(4):263-5.
134. Hayden MS, West AP, Ghosh S. NF-kappaB and the immune response. Oncogene. 2006;25(51):6758-80.
135. Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet. 2012;379(9820):1045-55.
136. de Lemos ET, Oliveira J, Pinheiro JP, Reis F. Regular physical exercise as a strategy to improve antioxidant and anti-inflammatory status: benefits in type 2 diabetes mellitus. Oxidative medicine and cellular longevity. 2012;2012:741545.
137. Golbidi S, Badran M, Laher I. Antioxidant and anti-inflammatory effects of exercise in diabetic patients. Experimental diabetes research. 2012;2012:941868.
138. Michigan A, Johnson TV, Master VA. Review of the relationship between C-reactive protein and exercise. Molecular diagnosis and therapy. 2011;15(5):265-75.
139. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, et al. Position statement. Part one: Immune function and exercise. Exercise immunology review. 2011;17:6-63.
140. Goodwin GM. Symptom relief and facilitation of emotional processing. Eur. Neuropsychopharmacol. 2011;21(Suppl 4):S710-S5.
141. Beck AT. Depression: Causes and Treatment. Philadelphia: University of Pennsylvania Press; 1967.
142. Bower GH. Mood and memory. Am. Psychol. 1981;36(2):129-48.
143. Ellis HC, Ashbrook PW. Resource allocation model of the effect of depressed mood states on memory. In: Fiedler K, Forgas J, (editors.) Affect, Cognition and Social behavior. Toronto, ON, Canada: Hogrefe; 1988. p. 25-43.
144. Teasdale JD. Cognitive Vulnerability to Persistent Depression. Cognition and Emotion. 1988;2(3):247-74.
145. Nolen-Hoeksema S. Responses to depression and their effects on the duration of depressive episodes. J. Abnorm. Psychol. 1991;100(4):569-82.
146. Barnard PJ, Teasdale JD. Interacting cognitive subsystems: A systemic approach to cognitive-affective interaction and change. Cognition and Emotion. 1991;5(1):1-39.
147. Segal ZV, Williams JM, Teasdale JD, Gemar M. A cognitive science perspective on kindling and episode sensitization in recurrent affective disorder. Psychol. Med. 1996;26(2):371-80.
148. Fernandez PM, Goncalves OF, Buela-Casal G, Machado PP. [Comparative analysis of attributional style and self-esteem in a sample of depressed patients and normal control subjects]. Actas Esp. Psiquiatr. 2004;32(5):259-63.
149. Watters AJ, Williams LM. Negative biases and risk for depression; integrating selfreport and emotion task markers. Depress Anxiety. 2011;28(8):703-18.
150. Carroll BJ. Brain mechanisms in manic depression. Clin. Chem. 1994;40(2):303-8.
151. Ikemoto S. Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci. Biobehav. Rev. 2010;35(2):129-50.
152. Tremblay LK, Naranjo CA, Graham SJ, Herrmann N, Mayberg HS, Hevenor S, et al. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch. Gen. Psychiatry. 2005;62(11):1228-36.
153. Naranjo CA, Tremblay LK, Busto UE. The role of the brain reward system in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2001;25(4):781-823.
154. Le Merrer J, Becker JA, Befort K, Kieffer BL. Reward processing by the opioid system in the brain. Physiol. Rev. 2009;89(4):1379-412.
155. Smoski MJ, Felder J, Bizzell J, Green SR, Ernst M, Lynch TR, et al. fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder. J. Affect Disord. 2009;118(1-3):69-78.
156. Tremblay LK, Naranjo CA, Cardenas L, Herrmann N, Busto UE. Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine. Arch. Gen. Psychiatry. 2002;59(5):409-16.
157. Hasler G, Luckenbaugh DA, Snow J, Meyers N, Waldeck T, Geraci M, et al. Reward processing after catecholamine depletion in unmedicated, remitted subjects with major depressive disorder. Biol. Psychiatry. 2009;66(3):201-5.
158. Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J. Psychiatr. Res. 2008;43(1):76-87.
159. Blood AJ, Iosifescu DV, Makris N, Perlis RH, Kennedy DN, Dougherty DD, et al. Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. PLoS One. 2010;5(11):e13945.